Currently out of the existing stock ratings of Matthew Carletti, 303 are a BUY (92.66%), 24 are a HOLD (7.34%).

Matthew Carletti

Work Performance Price Targets & Ratings Chart

Analyst Matthew Carletti, currently employed at JMP, carries an average stock price target met ratio of 61.49% that have a potential upside of 39.02% achieved within 385 days.

Matthew Carletti’s has documented 620 price targets and ratings displayed on 35 stocks. The coverage is on Financial Services, Healthcare sectors.

Most recent stock forecast was given on BOW, Bowhead Specialty Holdings at 10-Sep-2026.

Wall Street Analyst Matthew Carletti

Analyst best performing recommendations are on LIFE (ATYR PHARMA).
The best stock recommendation documented was for PLMR (PALOMAR HOLDINGS) at 2/19/2020. The price target of $60 was fulfilled within 1 day with a profit of $2.58 (4.49%) receiving and performance score of 44.93.

Average potential price target upside

of $98.6 (15.9%) on Y (ALLEGHANY).
of $44.49 (22.73%) on CB (CHUBB LTD).
of $41.83 (85.9%) on GSHD (GOOSEHEAD INSURANCE).

ACGL Arch Capital Group Ltd AMSF AMERISAFE CB Chubb Ltd GSHD Goosehead Insurance HCI HCI Group HRTG Heritage Insurance Hldgs NGHC National General Holdings Corp PLMR Palomar Holdings PRA ProAssurance ROOT Root THG The Hanover Insurance Group TIG Trean Insurance Group WTRE WisdomTree New Economy Real Estate ETF DOMA Doma Holdings LMND Lemonade SIGI Selective Insurance Group KMPR Kemper MHLD Maiden Holdings Ltd Y Alleghany HIPO Hippo Holdings JRVR James River Group Holdings Ltd KNSL Kinsale Capital Group ORI Old Republic International Corp RYAN Ryan Specialty Group Holdings HMN Horace Mann Educators RLI RLI Corp BOW Bowhead Specialty Holdings FIHL Fidelis Insurance Holdings HG Hamilton Insurance Group, Ltd. SKWD Skyward Specialty Insurance Group, Common Stock CBC STC Stewart Information Services Corp ARX BRO Brown & Brown LIFE aTyr Pharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Yaron Kinar (MIZUHO)

Hold Since 16-Dec-2025

$100

$6.4 (6.84%)

$104

18 days ago
(16-Sep-2026)

17/21 (80.95%)

$3.03 (3.12%)

179

Please subscribe to see extended stock data

Pablo Singzon (JPMORGAN)

Hold Since 20-Jul-2026

$118

$24.4 (26.07%)

$116

1 months 23 days ago
(11-Aug-2026)

0/2 (0%)

$19.74 (20.09%)

Please subscribe to see extended stock data

Ryan Tunis (CANTOR FITZGERALD)

Hold Since 17-Feb-2026

$110

$16.4 (17.52%)

$102

2 months 1 days ago
(03-Aug-2026)

3/4 (75%)

$8.88 (8.78%)

Please subscribe to see extended stock data

Rowland Mayor (RBC)

Buy Since 25-Nov-2025

$120

$26.4 (28.21%)

$115

2 months 4 days ago
(30-Jul-2026)

0/3 (0%)

$18.86 (18.65%)

Please subscribe to see extended stock data

Elyse Greenspan (WELLS FARGO)

Buy Since 06-Jan-2020

$117

$23.4 (25.00%)

$114

2 months 4 days ago
(30-Jul-2026)

24/38 (63.16%)

$15.86 (15.68%)

259

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Matthew Carletti most bullish on?

Potential upside of $80.75 has been obtained for HCI (HCI GROUP)

Which stock is Matthew Carletti most reserved on?

Potential downside of -$1.12 has been obtained for LIFE (ATYR PHARMA)

What Year was the first public recommendation made by Matthew Carletti?

On 2011